Sterile Intraocular Inflammation Associated With Faricimab
This case series highlights the occurrence of rare, but potentially severe, intraocular inflammation associated with faricimab therapy. Although these findings do not prove causality and can only generate hypotheses for future investigations, these results suggest the importance of continuous surveillance and monitoring for patients undergoing faricimab therapy to promptly identify and manage potential adverse events.
Authors
- Sandrine Zweifel (ORCID: https://orcid.org/0000-0001-7431-1774)
- Mariano Cozzi (ORCID: https://orcid.org/0000-0001-7777-2461)
- Katrin Fasler (ORCID: https://orcid.org/0000-0002-0348-961X)
- Daniel Rudolf Muth (ORCID: https://orcid.org/0000-0003-3670-976X)
- Frank Blaser
- A. Ziegler
Institutions
- University of Milan (IT)
- University of Zurich (CH)
- Karolinska Institutet (SE)
- University Hospital of Zurich (CH)
- S:t Eriks Ögonsjukhus (SE)
Publication Details
- Journal
- JAMA Ophthalmology
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1001/jamaophthalmol.2024.3828
- Citations
- 32
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 17.24